Search Results - "Ferguson, Peter M."

The Prognostic Significance of Tumoral Melanosis.

Authors: Potter, Alison J. Ferguson, Peter M. Lo, Serigne N. et al.

Source: Journal of Cutaneous Pathology. Jan2026, Vol. 53 Issue 1, p60-70. 11p.

In vivo reflectance confocal microscopy role for early to advanced lentigo maligna melanoma spectrum: A systematic review and pooled analysis.

Authors: Melhoranse Gouveia, Bruna Ferguson, Peter M. Lo, Serigne N. et al.

Source: Journal of the European Academy of Dermatology & Venereology. Mar2025, Vol. 39 Issue 3, p555-565. 11p.

Effect of MPATH‐Dx 2.0 on Diagnostic Agreement in the Histopathologic Assessment of Melanocytic Skin Lesions.

Authors: Lai, Belinda Zhu, Lin Ferguson, Peter M. et al.

Source: JEADV Clinical Practice. Mar2026, p1. 9p. 4 Illustrations, 2 Charts.

The tumour immune landscape and its implications in cutaneous melanoma.

Authors: Attrill, Grace H. Ferguson, Peter M. Palendira, Umaimainthan et al.

Source: Pigment Cell & Melanoma Research. May2021, Vol. 34 Issue 3, p529-549. 21p.

Using Magnetic Resonance Imaging to Evaluate Dendritic Cell-Based Vaccination

Authors: Ferguson, Peter M. Slocombe, Angela Tilley, Richard D. et al.

Source: PLoS ONE. May2013, Vol. 8 Issue 5, p1-12. 12p.

Strongly Magnetic Iron Nanoparticles Improve the Diagnosis of Small Tumours in the Reticuloendothelial System by Magnetic Resonance Imaging.

Authors: Ferguson, Peter M. Feindel, Kirk W. Slocombe, Angela et al.

Source: PLoS ONE. Feb2013, Vol. 8 Issue 2, p1-7. 7p.

A randomised pilot trial of perioperative propranolol combined with celecoxib versus standard of care in stage III melanoma: The ProCel study protocol.

Authors: Selvaraj, Katina J. Damian, Diona L. Lyons, J. Guy et al.

Source: PLoS ONE. 1/29/2025, Vol. 21 Issue 1, p1-8. 8p.

Complex melanoma of the scalp: Diagnosis and management aided by confocal microscopy.

Authors: Regio Pereira, Amanda Guitera, Pascale Ferguson, Peter M et al.

Source: Australasian Journal of Dermatology. Feb2022, Vol. 63 Issue 1, p105-109. 5p. 3 Color Photographs.

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.

Authors: Orlow, Irene Sadeghi, Keimya D. Edmiston, Sharon N. et al.

Source: PLoS ONE. 4/3/2023, Vol. 18 Issue 4, p1-25. 25p.

The impact of providing clinical images and dermoscopy reports on the diagnosis of melanocytic skin lesions.

Authors: Lai, Belinda Soyer, Hans Peter Zhu, Lin et al.

Source: Journal of the European Academy of Dermatology & Venereology. Jul2025, Vol. 39 Issue 7, pe634-e637. 4p.

Dermoscopic features and screening strategies for the detection of small‐diameter melanomas.

Authors: Regio Pereira, Amanda Corral‐Forteza, Marina Collgros, Helena et al.

Source: Clinical & Experimental Dermatology. May2022, Vol. 47 Issue 5, p932-941. 10p. 1 Color Photograph, 1 Diagram, 4 Charts.

Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma.

Authors: van der Weyden, Louise Velasco-Herrera, Martin Del Castillo Cheema, Saamin et al.

Source: British Journal of Dermatology. Feb2025, Vol. 192, p335-343. 9p.

Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategy.

Authors: van der Weyden, Louise Velasco-Herrera, Martin Del Castillo Cheema, Saamin et al.

Source: British Journal of Dermatology. Mar2025, Vol. 192 Issue 3, p551-553. 3p.

Inter‐ and intrapatient heterogeneity of indoleamine 2,3‐dioxygenase expression in primary and metastatic melanoma cells and the tumour microenvironment.

Authors: Gide, Tuba N Allanson, Benjamin M Menzies, Alexander M et al.

Source: Histopathology. May2019, Vol. 74 Issue 6, p817-828. 12p. 2 Charts, 4 Graphs.

In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case–control study.

Authors: Gouveia, Bruna Melhoranse Carlos, Giuliana Wadell, Andreanne et al.

Source: Journal of the European Academy of Dermatology & Venereology. Jul2023, Vol. 37 Issue 7, p1293-1301. 9p.

A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy.

Authors: Anderson, Regan J Tang, Ching-wen Daniels, Naomi J et al.

Source: Nature Chemical Biology. Nov2014, Vol. 10 Issue 11, p943-949. 7p.

Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?

Authors: Semsarian, Caitlin R. Ma, Tara Nickel, Brooke et al.

Source: British Journal of Dermatology. Jun2022, Vol. 186 Issue 6, p1030-1032. 3p.

Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.

Authors: Newell, Felicity Pires da Silva, Ines Johansson, Peter A. et al.

Source: Cancer Cell. Mar2025, Vol. 43 Issue 3, p563-563. 1p.

Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF^V600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.

Authors: Long, Georgina V Saw, Robyn P M Lo, Serigne et al.

Source: Lancet Oncology. Jul2019, Vol. 20 Issue 7, p961-971. 11p.

Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets.

Authors: Gide, Tuba N. Pires da Silva, Inês Quek, Camelia et al.

Source: Cancers. Jul2021, Vol. 13 Issue 13, p3186-3186. 1p.